Inadequate testing can have several adverse consequences for cancer patients:
Delayed Diagnosis: Late detection often results in cancer being diagnosed at a more advanced stage, reducing the chances of successful treatment. Misdiagnosis: Inaccurate or incomplete testing can lead to incorrect diagnoses, resulting in inappropriate or ineffective treatments. Increased Healthcare Costs: Delayed or incorrect diagnoses can lead to more complex and expensive treatments, increasing overall healthcare costs. Reduced Survival Rates: Early detection is key to improving survival rates; inadequate testing undermines this advantage.
